Vanguard Group
CLRB icon

Vanguard Group’s Cellectar Biosciences CLRB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$401K Sell
56,341
-1,665,497
-97% -$11.8M ﹤0.01% 3972
2025
Q1
$542K Sell
1,721,838
-5,163
-0.3% -$1.63K ﹤0.01% 3866
2024
Q4
$516K Buy
1,727,001
+15
+0% +$4 ﹤0.01% 3945
2024
Q3
$3.7M Buy
1,726,986
+163,000
+10% +$349K ﹤0.01% 3381
2024
Q2
$3.91M Buy
1,563,986
+372,905
+31% +$932K ﹤0.01% 3356
2024
Q1
$4.74M Buy
1,191,081
+708,191
+147% +$2.82M ﹤0.01% 3318
2023
Q4
$1.34M Buy
482,890
+307,006
+175% +$850K ﹤0.01% 3735
2023
Q3
$464K Buy
175,884
+3,911
+2% +$10.3K ﹤0.01% 4070
2023
Q2
$335K Sell
171,973
-3,510
-2% -$6.84K ﹤0.01% 4217
2023
Q1
$251K Hold
175,483
﹤0.01% 4284
2022
Q4
$300K Buy
175,483
+106
+0.1% +$181 ﹤0.01% 4223
2022
Q3
$589K Sell
175,377
-1,578,423
-90% -$5.3M ﹤0.01% 4169
2022
Q2
$708K Hold
1,753,800
﹤0.01% 4193
2022
Q1
$1.21M Sell
1,753,800
-207,505
-11% -$143K ﹤0.01% 4151
2021
Q4
$1.3M Sell
1,961,305
-2,905
-0.1% -$1.93K ﹤0.01% 4184
2021
Q3
$1.82M Buy
1,964,210
+89,626
+5% +$82.9K ﹤0.01% 4090
2021
Q2
$2.23M Buy
1,874,584
+231,180
+14% +$275K ﹤0.01% 3941
2021
Q1
$2.65M Buy
1,643,404
+129,872
+9% +$209K ﹤0.01% 3800
2020
Q4
$3.15M Buy
1,513,532
+1,442,695
+2,037% +$3M ﹤0.01% 3543
2020
Q3
$88K Buy
70,837
+54,082
+323% +$67.2K ﹤0.01% 4029
2020
Q2
$21K Hold
16,755
﹤0.01% 4060
2020
Q1
$22K Hold
16,755
﹤0.01% 4043
2019
Q4
$38K Hold
16,755
﹤0.01% 4059
2019
Q3
$34K Hold
16,755
﹤0.01% 4104
2019
Q2
$37K Hold
16,755
﹤0.01% 4129
2019
Q1
$39K Hold
16,755
﹤0.01% 4074
2018
Q4
$26K Hold
16,755
﹤0.01% 4108
2018
Q3
$50K Sell
16,755
-230,247
-93% -$687K ﹤0.01% 4127
2018
Q2
$153K Buy
247,002
+2,776
+1% +$1.72K ﹤0.01% 4008
2018
Q1
$277K Buy
244,226
+6,800
+3% +$7.71K ﹤0.01% 3909
2017
Q4
$325K Buy
237,426
+90,218
+61% +$123K ﹤0.01% 3841
2017
Q3
$246K Hold
147,208
﹤0.01% 3877
2017
Q2
$240K Buy
147,208
+35,482
+32% +$57.8K ﹤0.01% 3871
2017
Q1
$253K Buy
111,726
+41,541
+59% +$94.1K ﹤0.01% 3867
2016
Q4
$85K Buy
70,185
+28,952
+70% +$35.1K ﹤0.01% 3988
2016
Q3
$111K Buy
41,233
+17,701
+75% +$47.7K ﹤0.01% 3967
2016
Q2
$81K Buy
+23,532
New +$81K ﹤0.01% 4044